Cruciferous veggies may ward off bladder cancer

Fri May 25, 2007 3:50pm EDT
 
[-] Text [+]

NEW YORK (Reuters Health) - Substances found in cruciferous vegetables, like broccoli and cauliflower, may help protect people from bladder cancer, a new study shows.

People who consumed the most of these substances, called isothiocyanates (ITCs), had a 29-percent lower risk of the disease than those who consumed the least, Dr. Hua Zhao and colleagues from the University of Texas M.D. Anderson Cancer Center in Houston found.

Studies in animals have found ITCs prevent tumor growth, while epidemiological studies suggest they may lower lung and colon cancer risk, Zhao and his team note in the International Journal of Cancer. They point out that ITCs have detoxifying effects and can enhance the normal development of cells while promoting cell suicide in abnormal cells.

To investigate whether ITCs might protect against bladder cancer, the researchers compared ITC intake for 697 bladder cancer patients and 708 healthy controls. The average age of the subjects in both groups was 63 years old.

On average, the cancer patients consumed fewer ITCs than the healthy individuals. The average number of daily half-cup servings of cruciferous vegetables 1.76 for the healthy individuals and 1.41 for the cancer patients, a statistically significant difference.

High ITC intake reduced cancer risk by 29 percent. The patient factors with the strongest association with reduced risk included past smoking, current heavy smoking, older age and male sex.

The bladder may be particularly susceptible to the anti-cancer effects of ITCs, the researchers note, given that compounds produced by ITC metabolism are excreted through the urine.

"Our data provide strong evidence that consumption of ITCs from cruciferous vegetables protect against bladder cancer," the researchers conclude.

SOURCE: International Journal of Cancer, May 15, 2007.

 
Dr. Qurrath U. Ain of the Elmhurst Pediatric Emergency Center examines a patient with flu-like symptoms at Elmhurst Hospital in New York in this December 12, 2003. file photo. REUTERS/Shannon Stapleton/Files
Healthcare Reform

Reuters provides an in-depth look at the issues facing Americans as the Obama administration wrestles with healthcare policy.  Full Coverage 

Editor's Choice

A selection of our best photos from the past 24 hours.  Slideshow 

Most Popular on Reuters

  • Articles
  • Video
A pharmacist holds bottles of the prescription arthritis and pain medication VIOXX at a New York City Pharmacy after manufacturer Merc Research Laboratories announced a worldwide voluntary withdrawal of the drug September 30, 2004
Risky negotiations

While the government may be able to negotiate prescription cost-savings up front, the long term effect would hurt pharmaceutical innovation, writes Peter J. Pitts   Commentary | Full Coverage 

Join the Reuters Consumer Insight Panel and help us get to know you better

Join the Reuters Consumer Insight Panel and help us get to know you better